Engineering a packaging nanomotor for delivery of RNA and other molecules
设计用于递送 RNA 和其他分子的包装纳米马达
基本信息
- 批准号:7904763
- 负责人:
- 金额:$ 16.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2011-12-31
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAffinity ChromatographyAgar Gel ElectrophoresisArginineBacteriophage T4BiologicalBiological AssayCellsChargeComputer Systems DevelopmentDNADNA Groove BindingDNA PackagingDataDevicesDouble-Stranded RNAEngineeringFingersFoundationsFrequenciesGoalsHybridsIn VitroInfectionMeasurementMotorMutagenesisMutationNucleic AcidsPeptidesPharmacotherapyProteinsRNARestRoentgen RaysSchemeSepharoseShapesSolutionsSpecificityStructural BiochemistryStructural ModelsStructureSubstrate SpecificitySystemTestingTherapeuticVariantVertebral columnViral Packagingdesignds-DNAhigh throughput screeningimprovedinorganic phosphateinterestlaser tweezermutantnanobiotechnologynanomachinenovelnucleaseoverexpressionpublic health relevancesingle moleculetranslocase
项目摘要
DESCRIPTION (provided by applicant): One of the biggest challenges in nanobiotechnology is to engineer a biological component to carry out a specific task. The goal of this application is to engineer the bacteriophage T4 DNA packaging motor to translocate double stranded RNA and RNA:DNA hybrid molecules. The ability to alter the translocation specificity of the motor will greatly enhance its potential as a delivery nanomachine; adapting the existing machinery to transport a therapeutic molecule of interest into cells. The X-ray and cryo-EM structures of the phage T4 packaging motor have been recently determined. The motor protein, gp17, consists of several parts; ATPase (the engine), translocase (the wheel) and arginine finger (the spark plug). The translocation specificity is determined by a DNA binding groove that is well- separated from the rest of the motor. The shape and size of the groove fit a double stranded DNA molecule, and the distribution of positively charged residues lining the groove follows the pitch of the double helix; interacting with the backbone phosphates. These features suggest that the packaging motor is amendable to design novel motors with altered specificity. The translocation groove of gp17 will be mutagenized by error-prone and overlap extension PCR to introduce ~3 mutations per groove. Hundreds, if not thousands, of variants will be screened for the ability to translocate RNA in a high-throughput format. The his-tagged mutants will be overexpressed in E.coli and purified by affinity chromatography using 96-well Ni-Sepharose plates. An established defined in vitro packaging assay consisting of purified proheads, the packaging motor, ATP, and nucleic acid will be used to rapidly screen for RNA translocation mutants. This assay assembles the packaging machine in solution, and translocation into proheads is assessed by the presence of nuclease-protected RNA following agarose gel electrophoresis. The simplicity of this system lends itself well to the high-throughput format, allowing hundreds of mutant proteins and several different nucleic acids to be tested. The gp17 RNA translocation mutants identified in the high-throughput screen will be purified and analyzed for packaging ATPase, efficiency, and substrate specificity. Structural modeling of the mutant translocation grooves will be guided by the already determined crystal structures of the motor protein and its domains. Single molecule studies will be performed using optical tweezers to analyze motor dynamics; force, power, and rate, as well as frequency of slips or pauses; identifying subtle mechanistic differences between DNA and RNA translocation. Together, these findings will establish the design principles for further engineering of the motor to improve specificity and/or efficiency of RNA translocation. The proof of principle data generated from this application will provide a broader foundation for the application of the phage T4 packaging motor as a versatile nanomachine.
PUBLIC HEALTH RELEVANCE: A major challenge in nanobiotechnology is the ability to engineer new or improved biological devices for a specific purpose. The current application aims to use an established scheme of mutagenesis, biochemistry, structural analysis, and biophysical measurements and apply it to the design of a novel nanomachine from a well-defined viral packaging motor. This project will provide proof of principle data for the development of this system into a versatile delivery vehicle, delivering DNA, RNA, peptide, or drug therapy into the cell.
描述(由申请人提供):纳米生物技术的最大挑战之一是设计一种生物组件来执行特定的任务。该应用的目的是设计噬菌体T4 DNA包装电机以易位双链RNA和RNA:DNA混合分子。改变电动机的易位特异性的能力将大大提高其作为输送纳米机械的潜力。调整现有机械以将兴趣的治疗分子传输到细胞中。最近已经确定了噬菌体T4包装电机的X射线和冷冻EM结构。运动蛋白GP17由几个部分组成。 ATPase(发动机),易位酶(车轮)和精氨酸手指(火花塞)。易位特异性由DNA结合凹槽确定,该凹槽与电动机的其余部分分开。凹槽的形状和尺寸适合双链DNA分子,凹槽内衬有正电荷的残基的分布遵循双螺旋的螺距;与主链磷酸盐相互作用。这些功能表明,包装电动机是可以修改的,以设计具有改变特异性的新型电动机。 GP17的易位凹槽将通过容易出错的和重叠的延伸PCR进行诱变,以引入每个凹槽的3个突变。将筛选数百种(即使不是数千个)的变体,以使其具有高通量格式的RNA转移RNA。 His标记的突变体将在大肠杆菌中过表达,并使用96孔Ni-Sepharose板通过亲和色谱法纯化。已建立的定义的体外包装测定法,该测定法包括纯化的Prohead,包装电机,ATP和核酸将用于快速筛选RNA易位突变体。该测定法在溶液中组装了包装机,并通过琼脂糖凝胶电泳后的受核酸酶保护的RNA的存在来评估易位。该系统的简单性非常适合高通量格式,可以测试数百种突变蛋白和几种不同的核酸。在高通量屏幕中鉴定出的GP17 RNA易位突变体将被纯化并分析以包装ATPase,效率和底物特异性。突变体易位凹槽的结构建模将由运动蛋白及其结构域的已经确定的晶体结构指导。单分子研究将使用光学镊子进行分析运动动力学。力,功率和速率,以及滑动或暂停的频率;确定DNA和RNA易位之间的细微机械差异。这些发现将共同建立用于进一步工程电动机的设计原理,以提高RNA易位的特异性和/或效率。从本应用程序生成的原理数据证明将为将噬菌体T4包装电机作为多功能纳米机器的应用提供更广泛的基础。
公共卫生相关性:纳米生物技术的主要挑战是为特定目的设计新的或改进的生物设备的能力。当前的应用旨在使用既定的诱变,生物化学,结构分析和生物物理测量方案,并将其应用于从明确定义的病毒包装运动中的新型纳米机器的设计中。该项目将提供原理数据的证明,以将该系统开发为多功能输送车辆,将DNA,RNA,肽或药物治疗输送到细胞中。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Venigalla B. Rao其他文献
T4DNAパッケージング蛋白質gp16およびgp17の相互作用の解析
T4DNA包装蛋白gp16和gp17之间的相互作用分析
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
藤田大悟;金丸周司;Venigalla B. Rao;有坂文雄 - 通讯作者:
有坂文雄
Effect of ATPase-Defective Mutant Doping on Functionality and Dynamics of Single Bacteriophage T4 DNA Packaging Motors
- DOI:
10.1016/j.bpj.2020.11.398 - 发表时间:
2021-02-12 - 期刊:
- 影响因子:
- 作者:
Suoang Lu;Vishal I. Kottadiel;Li Dai;Digvijay Singh;Taekjip Ha;Venigalla B. Rao;Yann R. Chemla - 通讯作者:
Yann R. Chemla
Regulation of a Viral Packaging Motor's Grips on DNA
- DOI:
10.1016/j.bpj.2017.11.542 - 发表时间:
2018-02-02 - 期刊:
- 影响因子:
- 作者:
Mariam Ordyan;Douglas E. Smith;Venigalla B. Rao;Istiaq Alam;Marthandan Mahalingam - 通讯作者:
Marthandan Mahalingam
Analyzing DNA Packaging Initiation of Bacteriophage T4 by a Real-Time Single Molecule Fluorescence Assay
- DOI:
10.1016/j.bpj.2011.11.3497 - 发表时间:
2012-01-31 - 期刊:
- 影响因子:
- 作者:
Reza Vafabakhsh;Kiran Kondabagil;Li Dai;Zhihong Zhang;Venigalla B. Rao;Taekjip Ha - 通讯作者:
Taekjip Ha
Venigalla B. Rao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Venigalla B. Rao', 18)}}的其他基金
Structural Mechanisms Of Genome Flow In Bacteriophage T4 And Their Biomedical Applications
噬菌体T4基因组流动的结构机制及其生物医学应用
- 批准号:
10635661 - 财政年份:2023
- 资助金额:
$ 16.18万 - 项目类别:
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart
使用噬菌体 T4 Nanopart 的单剂量、多价炭疽鼠疫疫苗
- 批准号:
8819513 - 财政年份:2014
- 资助金额:
$ 16.18万 - 项目类别:
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart
使用噬菌体 T4 Nanopart 的单剂量、多价炭疽鼠疫疫苗
- 批准号:
8694624 - 财政年份:2014
- 资助金额:
$ 16.18万 - 项目类别:
Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart
使用噬菌体 T4 Nanopart 的单剂量、多价炭疽鼠疫疫苗
- 批准号:
9000614 - 财政年份:2014
- 资助金额:
$ 16.18万 - 项目类别:
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines
有效的噬菌体 T4 衍生 V2 免疫原作为 HIV 疫苗
- 批准号:
8494569 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines
有效的噬菌体 T4 衍生 V2 免疫原作为 HIV 疫苗
- 批准号:
8685883 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines
有效的噬菌体 T4 衍生 V2 免疫原作为 HIV 疫苗
- 批准号:
8868023 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Potent Phage T4 Derived V2 Immunogens as HIV Vaccines
有效的噬菌体 T4 衍生 V2 免疫原作为 HIV 疫苗
- 批准号:
8410257 - 财政年份:2012
- 资助金额:
$ 16.18万 - 项目类别:
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display
使用噬菌体 T4 展示多价鼠疫、炭疽疫苗
- 批准号:
8435493 - 财政年份:2009
- 资助金额:
$ 16.18万 - 项目类别:
Multivalent Plague, Anthrax Vaccines Using Bacteriophage T4 Display
使用噬菌体 T4 展示多价鼠疫、炭疽疫苗
- 批准号:
7644596 - 财政年份:2009
- 资助金额:
$ 16.18万 - 项目类别:
相似国自然基金
基于亲和导向-邻近反应的复杂体系天然蛋白固定新方法及色谱评价
- 批准号:22374116
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于亲和色谱策略筛选和挖掘磷酸酶PP2A新型调节剂
- 批准号:22377149
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
- 批准号:82160027
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于亲和色谱靶点“钩钓”策略研究补肾活血方抗AGEs诱导神经损伤的作用机制
- 批准号:82104621
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
固定化单构象态受体亲和色谱的建立及止喘灵方平喘功效物质研究
- 批准号:82174088
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
相似海外基金
Engineering a packaging nanomotor for delivery of RNA and other molecules
设计用于递送 RNA 和其他分子的包装纳米马达
- 批准号:
7712849 - 财政年份:2009
- 资助金额:
$ 16.18万 - 项目类别: